Sickle Cell TraitTDexNCT04028791
Sickle Cell Trait and Exercise, Effect of Hot Environment
A study testing Exercise on ergocycle in people with Sickle Cell Trait and Environmental Exposure, run by University of the French West Indies and French Guiana at 1 site in Guadeloupe.
Trial summary
The heterozygous form of sickle cell disease is clinically asymptomatic. Nevertheless, it was observed that, the sickle cell trait is associated with serious medical complications especially during intense physical efforts. Read more about this study
- Who is it for?
- Ages 18 to 30 years, men onlyHealthy volunteers can take part
- Conditions the study is for
- Sickle Cell Trait, Environmental Exposure, Adverse Effect
- What is being tested?
- Exercise on ergocycle
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 21 participants
- Where
- 1 siteGuadeloupe
- Study dates
- 25 Sep 2017to 1 Jul 2019
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 30 years
- Men only
- Healthy volunteers accepted
- Adult
Who may be able to join
- BMI between 19 and 25kg/m2,
- Be living in the Caribbean for at least 6 months health
- Be physically active (≥ 1350 METs/week)
- No history of heat stroke during exercise
- No taking any medications
- Not regularly consuming alcohol
- Have the ability and willingness to issue consent written, free and enlightened
Who cannot join
- Have any other hemoglobinemic status than AA or AS.
- Weight gain or loss of more than 2 kg in the last 6 month.
- Food allergy to any of ingredients coming into the composition of test meals or that may result from a cross-contamination during manufacture: eggs and eggs products, gluten, milk and milk-based products (including lactose), soybean and soy products, fruit hulls (almonds, hazelnuts, walnuts, cashew nuts, pecan, macadamia, Brazil, Queensland, pistachios) and products made of these fruits.
- Monitoring a particular diet
- Any chronic metabolic pathology, cardiovascular, neurovascular, renal, respiratory, neuromuscular, musculoskeletal or articular known
- Any disorder of the ear (infections, tumors, perforated eardrums, polyps)
- Any infectious disease or inflammatory and infectious condition
Trial locations and contacts
1 site in 1 country.
About this study
Official title: Metabolic and Vascular Response to Exercise in Sickle Cell Trait Carriers: Effect of Hot Environment
The heterozygous form of sickle cell disease is clinically asymptomatic. Nevertheless, it was observed that, the sickle cell trait is associated with serious medical complications especially during intense physical efforts. Moreover, the exposure to a hot environment (tropical climate) is suspected to be a determining factor in the occurrence of these medical complications.
However, the relationship between sickle cell trait and death during effort is not well established. Furthermore, the cascade of events that usually cause sickle cell crisis such as red blood cells sickling and rhabdomyolysis and which affect microcirculation are not known.
Read more
Our main objective in this study is to verify whether young healthy active men with sickle cell trait have reactive hyperemia to their hemoglobinemic condition during exercise; to identify the contribution of hot environment on these possible disturbances; and to determine underlying mechanisms.
In addition, disturbances in the regulation of glucose metabolism in healthy subjects under hot environment have been reported, marked by a significant increase in postprandial blood glucose. Therefore, this project is also intended to assess the contribution of the disturbance of glycoregulation during exercise under hot environment in active sickle cell trait carriers. The imbalance of pro and anti oxidant agents, the adhesion and inflammation markers will also be evaluated.
Results of this study will allow a better understanding of physio-pathological mechanisms leading to vascular accidents during exercise under tropical climate in young healthy sickle cell trait carriers; and to identify physical activity programs and nutritional interventions adapted to patients with sickle cell disease under hot environment.
Read the detailed description
Introduction
The sickle cell disease is an inherited disorder characterized by abnormal hemoglobin called hemoglobin S or sickle hemoglobin in red blood cells of subjects. The homozygous form (hemoglobin SS) causes sickle cell anemia and is the most severe kind of sickle cell disease. Hemoglobin SC disease and hemoglobin Sβ thalassemia are two other common forms of sickle cell disease. The sickle cell trait carriers are person who inherited the hemoglobin S from one parent and a normal hemoglobin A from the other (heterozygous AS). These people are generally healthy. However, more and more cases of serious complications have been reported, especially during efforts and stays at high altitude like hemorheological and microcirculatory disturbances, and rhabdomyolysis. Increased percentage of red cell sicking was observed in sickle cell trait (AS) carriers compared to normal individual after 45 min of walking at 33°C of temperature. AS individuals also showed an impairment in red blood deformability at rest, at the end, and 24 hours after maximal exercise as compared to normal individuals AA, showing the vulnerability of red blood cells of these seemingly healthy subjects. The stiffness of red blood cells along with blood viscosity also increased in AS group compared to AA group, as consequence the risk of vascular accidents increases. In athletes and military warfighters, an exercise collapse and sudden death associated with sickle cell trait has been observed. Several cases of sudden death in AS individuals have been reported by many authors during exercise, however the exact causes remain very poorly understood.
As constraints related to exercise in tropical climate, it was observed a reduction of power and volemia due to dehydration, diversion of blood volume to the cutaneous territories. It was also reported an impairment of carbohydrate metabolism.
Our objectives in this work are:
- To characterize the microvascular response to exercise in a hot environment in sickle cell trait active young adults,
- To highlight biological mechanisms underlying any microvascular response specificities of the sickle cell trait carriers,
- To describe the vascular consequences of postprandial metabolic disturbances induced by exercise in hot environment,
- To understand fasting and post-prandial glucose metabolism at rest, during and after exercise,
- To test the recovery in a neutral thermal environment (22 °C) as a means of normalizing post-exercise vascular function.
Experimental protocol
Thirty male volunteers (15 healthy: AA and 15 sickle cell trait carriers: AS) non-smoking, aged 18-30 years, BMI between 19 and 25kg/m2 living in the Caribbean for at least 6 months will be enrolled in the study. All subjects will be in good health physically active (≥ 3h/week) with no history of heat stroke during exercise. They are not taking any medications and are not regularly consume alcohol.
Participants will be subjected to four experimental sessions:
- A familiarization session at fasting in a warm environment (33 °C) in which resting parameters like reactive hyperemia index, tympanic temperature, heart rate, cerebral and muscular oxygenation, pulse wave velocity and electrocardiogram (ECG) will be measured. Then a test of the intensity of exercise (VO2max) will be performed followed by a medical interview. The other 3 sessions will be performed early in the morning at fasting with 45 minutes of exercise on ergocycle. The exercise includes 15 minutes of warm up, then participants will be asked to pedal as fast as possible for 6 seconds. The test of 6 seconds will be repeated twice or more with recovery each time. During exercise, hydration will be controlled (2.5 ml water / kg every 15 minutes), oxygen consumption will be measured; and microvascular function and blood samples taken at different times of experiment in each session (T0, T60, T75, T90, T120). The design of this study is a crossover trial divided into 3 sessions presented in randomized order:
- Exercise performed in hot environment (33 °C) with recovery in the same environment.
- Exercise and recovery performed in a control (thermoneutral) environment (22 °C)
- Exercise performed in a hot environment (33 °C) with recovery in a thermoneutral environment (22 °C).
At the end of each session, a standardized meal will be given to each participant.
This study will be conducted in accordance with the guidelines developed in the Declaration of Helsinki, and all procedures were approved by the Committee for the Protection of Persons East-III. Written informed consent will be obtained from all participants.
Biochemical procedures
Blood samples will be use for hemorheological tests (viscosity of blood, stiffness, aggregability and sickling of red cells etc.) Dosage of creatine kinase (CK-MM, MB), myoglobin and troponin will be performed to assess the degree of rhabdomyolysis and the integrity of heart.
Glycemia and lactatemia will be determined using strips. Cortisol, insulin, adrenalin, glucagon and lactate dehydrogenase (LDH) assays will be performed using appropriated kits.
Plasma inflammatory profile will be determined by measuring markers such as myeloperoxidase (MPO), malondialdehyde (MDA), advanced oxidation protein products (AOPP), nitrotyrosin, and endothelin-1 using appropriated kits.
Adhesion molecules such as VCAM-1, ICAM-1 and P-selectin will be measured using ELISA kit from Diaclone or Eurobio.
The oxidative stress on red blood cells will be assessed by measuring glutathione ratio GSSH/GSSG, superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx).
Statistical analysis Data will be expressed as means with their standard errors. Statistical analyses will be performed with SPSS for MAC and p < 0·05 considered statistically significant.
All the data will be analysed by using repeated-measures ANOVA followed by Post hoc comparisons with the Student's paired t test. The tests of Kolmogorov-Smirnov, Newman Keuls and Duncan will be applied as appropriate.
Expected outcomes
- Better understanding of physio-pathological mechanisms leading to severe vascular events following physical exercise in tropical climate in healthy sickle cell carriers.
- Opening of tracks for identification of physical activity programs and nutritional interventions adapted to sickle cell patients in hot environment.
- Understanding of mechanisms leading to disturbances of glucose metabolism under tropical climate in AA and in AS subjects.
- Conditions
- Sickle Cell Trait, Environmental Exposure, Adverse Effect
- Being tested
- Exercise on ergocycle
- Keywords
- Exercise, sickling, rhamdomyolysis, oxidative stress
- Medical subject headings
- Sickle Cell Trait, Motor Activity
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Exercise on ergocycleOther
The exercise includes 15 minutes of warm up, then participants will be asked to pedal as fast as possible for 6 seconds. The test of 6 seconds will be repeated twice or more with recovery each time
| Study group | Role | What they receive |
|---|---|---|
| AS and AA | Experimental | Participants will be submitted to 45 minutes of exercise on ergocycle. Receives: Other: Exercise on ergocycle |
What is being measured
The primary outcome is the main question the study is designed to answer.
Microvascular function
Reactive hyperemia index (arbitrary units) will be assessed at rest, during exercise and during recovery in hot and thermoneutral environment
Measured: 2 hours
Secondary outcomes (6)
Oxidative stress
Glutathione ratio GSSH/GSSG
Measured: 3 months
Inflammation
Myeloperoxidase (MPO)
Measured: 3 months
Adhesion molecules
VCAM-1
Measured: 3 mois
Hemorheology
hematocrit
Measured: 24 hours
Rhamdomyolysis
Creatine kinase
Measured: 3 months
Oxydative stress marker
superoxide dismutase (SOD)
Measured: 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted23 Jul 2019
- Study start25 Sep 2017
- Primary completion1 Jul 2019
- Study completion1 Jul 2019
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Publications (11)Papers the sponsor has linked to this study.
- Other trials for Sickle Cell TraitStudies of the same condition, open and under way.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Model description
- All participants in each group (AA, AS) will carry out the following 3 sessions: 1. Exercise performed in hot environment (33 °C) with recovery in the same environment 2. Exercise and recovery performed in a control (thermoneutral) environment (22 °C), 3. Exercise performed in a hot environment (33 °C) with recovery in a thermoneutral, environment (22 °C).
- Masking
- None (open label)
- Enrolment
- 21 participants (actual)
Sponsor and investigators
- Lead sponsor
- University of the French West Indies and French Guiana
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Sophie Antoine-Jonville, University of the French West Indies and French Guiana
- Investigators
- Stéphane Henri, Dr, Principal investigator, Laboratoire ACTES, EA 3596 UFR STAPS, University of the French West Indies and French GuianaOlivier Hue, PhD, Study director, Laboratoire ACTES, EA 3596 UFR STAPS, University of the French West Indies and French GuianaMona Hedreville, Dr, Principal investigator, Unités Urgences cardiologiques CHU, Pointe-à-Pitre/Abymes 97159
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT04028791
- Sponsor's protocol ID
- 2017-A02226-47
- Acronym
- TDex
- Status last verified
- Jul 2019
- First submitted
- 16 Jul 2019
- Last updated
- 23 Jul 2019
- Results posted
- No
- Data monitoring committee
- Yes
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- Undecided: All autors have to discuss together before to decide
Publications
Bergeron MF, Cannon JG, Hall EL, Kutlar A. Erythrocyte sickling during exercise and thermal stress. Clin J Sport Med. 2004 Nov;14(6):354-6. doi: 10.1097/00042752-200411000-00005.
PubMed 15523207Connes P, Sara F, Hardy-Dessources MD, Marlin L, Etienne F, Larifla L, Saint-Martin C, Hue O. Effects of short supramaximal exercise on hemorheology in sickle cell trait carriers. Eur J Appl Physiol. 2006 May;97(2):143-50. doi: 10.1007/s00421-006-0155-3. Epub 2006 Feb 28.
PubMed 16506056Faure C, Charlot K, Henri S, Hardy-Dessources MD, Hue O, Antoine-Jonville S. Impaired glucose tolerance after brief heat exposure: a randomized crossover study in healthy young men. Clin Sci (Lond). 2016 Jun 1;130(12):1017-25. doi: 10.1042/CS20150461. Epub 2016 Mar 15.
PubMed 26980346Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987 Sep 24;317(13):781-7. doi: 10.1056/NEJM198709243171301.
PubMed 3627196Kerle KK, Nishimura KD. Exertional collapse and sudden death associated with sickle cell trait. Mil Med. 1996 Dec;161(12):766-7.
PubMed 8990839Kerle KK, Runkle GP. Sickle cell trait and sudden death in athletes. JAMA. 1996 Nov 13;276(18):1472. No abstract available.
PubMed 8903257Le Gallais D, Bile A, Mercier J, Paschel M, Tonellot JL, Dauverchain J. Exercise-induced death in sickle cell trait: role of aging, training, and deconditioning. Med Sci Sports Exerc. 1996 May;28(5):541-4. doi: 10.1097/00005768-199605000-00001.
PubMed 9148081Monchanin G, Connes P, Wouassi D, Francina A, Djoda B, Banga PE, Owona FX, Thiriet P, Massarelli R, Martin C. Hemorheology, sickle cell trait, and alpha-thalassemia in athletes: effects of exercise. Med Sci Sports Exerc. 2005 Jul;37(7):1086-92. doi: 10.1249/01.mss.0000170128.78432.96.
PubMed 16015123O'Connor FG, Bergeron MF, Cantrell J, Connes P, Harmon KG, Ivy E, Kark J, Klossner D, Lisman P, Meyers BK, O'Brien K, Ohene-Frempong K, Thompson AA, Whitehead J, Deuster PA. ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes. Med Sci Sports Exerc. 2012 Nov;44(11):2045-56. doi: 10.1249/MSS.0b013e31826851c2.
PubMed 22811029Quattrone RD, Eichner ER, Beutler A, Adams WB, O'Connor FG. Exercise collapse associated with sickle cell trait (ECAST): case report and literature review. Curr Sports Med Rep. 2015 Mar-Apr;14(2):110-6. doi: 10.1249/JSR.0000000000000137.
PubMed 25757006Wirthwein DP, Spotswood SD, Barnard JJ, Prahlow JA. Death due to microvascular occlusion in sickle-cell trait following physical exertion. J Forensic Sci. 2001 Mar;46(2):399-401.
PubMed 11305451
Study at a glance
From the registry record, last updated by the sponsor on 23 Jul 2019. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Metabolic and Vascular Response to Exercise in Sickle Cell Trait Carriers: Effect of Hot Environment
- ClinicalTrials.gov ID
- NCT04028791
- Acronym / sponsor ID
- TDex / 2017-A02226-47
- Conditions
- Sickle Cell Trait, Environmental Exposure, Adverse Effect
- Keywords
- Exercise, sickling, rhamdomyolysis, oxidative stress
- Study type
- Interventional
- Recruitment status
- Completed
- Enrolment
- 21 participants (actual)
- Lead sponsor
- University of the French West Indies and French GuianaUniversity, hospital or other
- Collaborators
- Institut National de la Santé Et de la Recherche Médicale, France
- Study start
- 25 Sep 2017 (actual)
- Primary completion
- 1 Jul 2019 (actual)
- Study completion
- 1 Jul 2019 (actual)
- First posted
- 23 Jul 2019 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
The heterozygous form of sickle cell disease is clinically asymptomatic. Nevertheless, it was observed that, the sickle cell trait is associated with serious medical complications especially during intense physical efforts. Moreover, the exposure to a hot environment (tropical climate) is suspected to be a determining factor in the occurrence of these medical complications.
However, the relationship between sickle cell trait and death during effort is not well established. Furthermore, the cascade of events that usually cause sickle cell crisis such as red blood cells sickling and rhabdomyolysis and which affect microcirculation are not known.
Our main objective in this study is to verify whether young healthy active men with sickle cell trait have reactive hyperemia to their hemoglobinemic condition during exercise; to identify the contribution of hot environment on these possible disturbances; and to determine underlying mechanisms.
In addition, disturbances in the regulation of glucose metabolism in healthy subjects under hot environment have been reported, marked by a significant increase in postprandial blood glucose. Therefore, this project is also intended to assess the contribution of the disturbance of glycoregulation during exercise under hot environment in active sickle cell trait carriers. The imbalance of pro and anti oxidant agents, the adhesion and inflammation markers will also be evaluated.
Results of this study will allow a better understanding of physio-pathological mechanisms leading to vascular accidents during exercise under tropical climate in young healthy sickle cell trait carriers; and to identify physical activity programs and nutritional interventions adapted to patients with sickle cell disease under hot environment.
Detailed description
Introduction
The sickle cell disease is an inherited disorder characterized by abnormal hemoglobin called hemoglobin S or sickle hemoglobin in red blood cells of subjects. The homozygous form (hemoglobin SS) causes sickle cell anemia and is the most severe kind of sickle cell disease. Hemoglobin SC disease and hemoglobin Sβ thalassemia are two other common forms of sickle cell disease. The sickle cell trait carriers are person who inherited the hemoglobin S from one parent and a normal hemoglobin A from the other (heterozygous AS). These people are generally healthy. However, more and more cases of serious complications have been reported, especially during efforts and stays at high altitude like hemorheological and microcirculatory disturbances, and rhabdomyolysis. Increased percentage of red cell sicking was observed in sickle cell trait (AS) carriers compared to normal individual after 45 min of walking at 33°C of temperature. AS individuals also showed an impairment in red blood deformability at rest, at the end, and 24 hours after maximal exercise as compared to normal individuals AA, showing the vulnerability of red blood cells of these seemingly healthy subjects. The stiffness of red blood cells along with blood viscosity also increased in AS group compared to AA group, as consequence the risk of vascular accidents increases. In athletes and military warfighters, an exercise collapse and sudden death associated with sickle cell trait has been observed. Several cases of sudden death in AS individuals have been reported by many authors during exercise, however the exact causes remain very poorly understood.
As constraints related to exercise in tropical climate, it was observed a reduction of power and volemia due to dehydration, diversion of blood volume to the cutaneous territories. It was also reported an impairment of carbohydrate metabolism.
Our objectives in this work are:
- To characterize the microvascular response to exercise in a hot environment in sickle cell trait active young adults,
- To highlight biological mechanisms underlying any microvascular response specificities of the sickle cell trait carriers,
- To describe the vascular consequences of postprandial metabolic disturbances induced by exercise in hot environment,
- To understand fasting and post-prandial glucose metabolism at rest, during and after exercise,
- To test the recovery in a neutral thermal environment (22 °C) as a means of normalizing post-exercise vascular function.
Experimental protocol
Thirty male volunteers (15 healthy: AA and 15 sickle cell trait carriers: AS) non-smoking, aged 18-30 years, BMI between 19 and 25kg/m2 living in the Caribbean for at least 6 months will be enrolled in the study. All subjects will be in good health physically active (≥ 3h/week) with no history of heat stroke during exercise. They are not taking any medications and are not regularly consume alcohol.
Participants will be subjected to four experimental sessions:
- A familiarization session at fasting in a warm environment (33 °C) in which resting parameters like reactive hyperemia index, tympanic temperature, heart rate, cerebral and muscular oxygenation, pulse wave velocity and electrocardiogram (ECG) will be measured. Then a test of the intensity of exercise (VO2max) will be performed followed by a medical interview. The other 3 sessions will be performed early in the morning at fasting with 45 minutes of exercise on ergocycle. The exercise includes 15 minutes of warm up, then participants will be asked to pedal as fast as possible for 6 seconds. The test of 6 seconds will be repeated twice or more with recovery each time. During exercise, hydration will be controlled (2.5 ml water / kg every 15 minutes), oxygen consumption will be measured; and microvascular function and blood samples taken at different times of experiment in each session (T0, T60, T75, T90, T120). The design of this study is a crossover trial divided into 3 sessions presented in randomized order:
- Exercise performed in hot environment (33 °C) with recovery in the same environment.
- Exercise and recovery performed in a control (thermoneutral) environment (22 °C)
- Exercise performed in a hot environment (33 °C) with recovery in a thermoneutral environment (22 °C).
At the end of each session, a standardized meal will be given to each participant.
This study will be conducted in accordance with the guidelines developed in the Declaration of Helsinki, and all procedures were approved by the Committee for the Protection of Persons East-III. Written informed consent will be obtained from all participants.
Biochemical procedures
Blood samples will be use for hemorheological tests (viscosity of blood, stiffness, aggregability and sickling of red cells etc.) Dosage of creatine kinase (CK-MM, MB), myoglobin and troponin will be performed to assess the degree of rhabdomyolysis and the integrity of heart.
Glycemia and lactatemia will be determined using strips. Cortisol, insulin, adrenalin, glucagon and lactate dehydrogenase (LDH) assays will be performed using appropriated kits.
Plasma inflammatory profile will be determined by measuring markers such as myeloperoxidase (MPO), malondialdehyde (MDA), advanced oxidation protein products (AOPP), nitrotyrosin, and endothelin-1 using appropriated kits.
Adhesion molecules such as VCAM-1, ICAM-1 and P-selectin will be measured using ELISA kit from Diaclone or Eurobio.
The oxidative stress on red blood cells will be assessed by measuring glutathione ratio GSSH/GSSG, superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx).
Statistical analysis Data will be expressed as means with their standard errors. Statistical analyses will be performed with SPSS for MAC and p < 0·05 considered statistically significant.
All the data will be analysed by using repeated-measures ANOVA followed by Post hoc comparisons with the Student's paired t test. The tests of Kolmogorov-Smirnov, Newman Keuls and Duncan will be applied as appropriate.
Expected outcomes
- Better understanding of physio-pathological mechanisms leading to severe vascular events following physical exercise in tropical climate in healthy sickle cell carriers.
- Opening of tracks for identification of physical activity programs and nutritional interventions adapted to sickle cell patients in hot environment.
- Understanding of mechanisms leading to disturbances of glucose metabolism under tropical climate in AA and in AS subjects.
Study design
- Primary purpose
- Screening
- Allocation
- Not applicable
- Intervention model
- Single group
- Masking
- None (open label)
- Number of arms
- 1
- Model description
- All participants in each group (AA, AS) will carry out the following 3 sessions: 1. Exercise performed in hot environment (33 °C) with recovery in the same environment 2. Exercise and recovery performed in a control (thermoneutral) environment (22 °C), 3. Exercise performed in a hot environment (33 °C) with recovery in a thermoneutral, environment (22 °C).
| Arm | Type | Receives |
|---|---|---|
| AS and AA | Experimental | Other: Exercise on ergocycleParticipants will be submitted to 45 minutes of exercise on ergocycle. |
Who may qualify
- Ages
- 18 to 30 years
- Sex
- Male only
- Healthy volunteers
- Accepted
- Age groups
- Adult
Key inclusion criteria (7 listed)
- BMI between 19 and 25kg/m2,
- Be living in the Caribbean for at least 6 months health
- Be physically active (≥ 1350 METs/week)
- No history of heat stroke during exercise
- No taking any medications
Key exclusion criteria (7 listed)
- Have any other hemoglobinemic status than AA or AS.
- Weight gain or loss of more than 2 kg in the last 6 month.
- Food allergy to any of ingredients coming into the composition of test meals or that may result from a cross-contamination during manufacture: eggs and eggs products, gluten, milk and milk-based products (including lactose), soybean and soy products, fruit hulls (almonds, hazelnuts, walnuts, cashew nuts, pecan, macadamia, Brazil, Queensland, pistachios) and products made of these fruits.
- Monitoring a particular diet
- Any chronic metabolic pathology, cardiovascular, neurovascular, renal, respiratory, neuromuscular, musculoskeletal or articular known
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Exercise on ergocycleThe exercise includes 15 minutes of warm up, then participants will be asked to pedal as fast as possible for 6 seconds. The test of 6 seconds will be repeated twice or more with recovery each time | Other | AS and AA |
Primary outcome
Microvascular function
Time frame: 2 hours
Reactive hyperemia index (arbitrary units) will be assessed at rest, during exercise and during recovery in hot and thermoneutral environment
6 secondary outcomes
Oxidative stress
Time frame: 3 months
Inflammation
Time frame: 3 months
Adhesion molecules
Time frame: 3 mois
Hemorheology
Time frame: 24 hours
Rhamdomyolysis
Time frame: 3 months
Oxydative stress marker
Time frame: 3 months
Results and safety
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 23 Jul 2019.
- Background: PubMed 15523207Bergeron MF, Cannon JG, Hall EL, Kutlar A. Erythrocyte sickling during exercise and thermal stress. Clin J Sport Med. 2004 Nov;14(6):354-6. doi: 10.1097/00042752-200411000-00005.
- Background: PubMed 16506056Connes P, Sara F, Hardy-Dessources MD, Marlin L, Etienne F, Larifla L, Saint-Martin C, Hue O. Effects of short supramaximal exercise on hemorheology in sickle cell trait carriers. Eur J Appl Physiol. 2006 May;97(2):143-50. doi: 10.1007/s00421-006-0155-3. Epub 2006 Feb 28.
- Background: PubMed 26980346Faure C, Charlot K, Henri S, Hardy-Dessources MD, Hue O, Antoine-Jonville S. Impaired glucose tolerance after brief heat exposure: a randomized crossover study in healthy young men. Clin Sci (Lond). 2016 Jun 1;130(12):1017-25. doi: 10.1042/CS20150461. Epub 2016 Mar 15.
- Background: PubMed 3627196Kark JA, Posey DM, Schumacher HR, Ruehle CJ. Sickle-cell trait as a risk factor for sudden death in physical training. N Engl J Med. 1987 Sep 24;317(13):781-7. doi: 10.1056/NEJM198709243171301.
- Background: PubMed 8990839Kerle KK, Nishimura KD. Exertional collapse and sudden death associated with sickle cell trait. Mil Med. 1996 Dec;161(12):766-7.
- Background: PubMed 8903257Kerle KK, Runkle GP. Sickle cell trait and sudden death in athletes. JAMA. 1996 Nov 13;276(18):1472. No abstract available.
- Background: PubMed 9148081Le Gallais D, Bile A, Mercier J, Paschel M, Tonellot JL, Dauverchain J. Exercise-induced death in sickle cell trait: role of aging, training, and deconditioning. Med Sci Sports Exerc. 1996 May;28(5):541-4. doi: 10.1097/00005768-199605000-00001.
- Background: PubMed 16015123Monchanin G, Connes P, Wouassi D, Francina A, Djoda B, Banga PE, Owona FX, Thiriet P, Massarelli R, Martin C. Hemorheology, sickle cell trait, and alpha-thalassemia in athletes: effects of exercise. Med Sci Sports Exerc. 2005 Jul;37(7):1086-92. doi: 10.1249/01.mss.0000170128.78432.96.
- Background: PubMed 22811029O'Connor FG, Bergeron MF, Cantrell J, Connes P, Harmon KG, Ivy E, Kark J, Klossner D, Lisman P, Meyers BK, O'Brien K, Ohene-Frempong K, Thompson AA, Whitehead J, Deuster PA. ACSM and CHAMP summit on sickle cell trait: mitigating risks for warfighters and athletes. Med Sci Sports Exerc. 2012 Nov;44(11):2045-56. doi: 10.1249/MSS.0b013e31826851c2.
- Background: PubMed 25757006Quattrone RD, Eichner ER, Beutler A, Adams WB, O'Connor FG. Exercise collapse associated with sickle cell trait (ECAST): case report and literature review. Curr Sports Med Rep. 2015 Mar-Apr;14(2):110-6. doi: 10.1249/JSR.0000000000000137.
- Background: PubMed 11305451Wirthwein DP, Spotswood SD, Barnard JJ, Prahlow JA. Death due to microvascular occlusion in sickle-cell trait following physical exertion. J Forensic Sci. 2001 Mar;46(2):399-401.
- Individual participant dataSharing planned: Undecided. All autors have to discuss together before to decide
Related trials for Sickle Cell Trait
RecruitingPhase 1
Study to Evaluate the Safety and Tolerability of Escalating Doses of Fostamatinib in Subjects With Stable Sickle Cell Disease
Sickle Cell Disorders, Sickle Cell Disease
RecruitingObservational study
Genotype -Phenotype Correlation of PKLR Variants With Pyruvate Kinase, 2,3-Diphosphglycerate and Adenosine Triphosphate Activities in Red Blood Cells of People With Sickle Cell Disease
Sickle Cell, PKLR Variants
RecruitingObservational study
Blood Sampling for Research Related to Sickle Cell Disease
Sickle Cell Trait, Sickle Cell Disease
Active, not recruiting
CHOICES3: Sickle Cell Disease Parenting CHOICES
Sickle Cell Disease, Sickle Cell Trait
Not yet recruitingObservational study
MENA/Levant Epidemiological, Registry of Immunological & Clinical Traits (MERIT)
Antiphospholipid (aPL)-Positive, Rheumatic Arthritis
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
Stéphane Henri, Dr principal investigator
Laboratoire ACTES, EA 3596 UFR STAPS, University of the French West Indies and French Guiana
Olivier Hue, PhD study director
Laboratoire ACTES, EA 3596 UFR STAPS, University of the French West Indies and French Guiana
Mona Hedreville, Dr principal investigator
Unités Urgences cardiologiques CHU, Pointe-à-Pitre/Abymes 97159
1 site in 1 country: see every site and its status.
Questions about this trial
What is this clinical trial studying?
A study testing Exercise on ergocycle in people with Sickle Cell Trait and Environmental Exposure, run by University of the French West Indies and French Guiana at 1 site in Guadeloupe.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 7 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: finished, as of the sponsor's last update on 23 Jul 2019. Status can change between updates, so confirm with the study contact before making plans.
Where is the study taking place?
The record lists 1 site in Guadeloupe. Whether a site is taking part right now should be confirmed with that site. See every site.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Microvascular function (time frame: 2 hours). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
On the ClinicalTrials.gov record for NCT04028791, which also lists 11 linked publications.
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Jul 2019.